Fumihiro Fujiki

Induction of <i>WT1</i> (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

Akihiro Tsuboi, Tetsuya Taguchi, Tadashi Osaki et al. · Proceedings of the National Academy of Sciences · 2004 · 526 citations · Full text

Medicine, Immunology, Oncology +17

Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

Sébastien Anguille, Ann L. Van de Velde, Evelien Smits et al. · Blood · 2017 · 233 citations · Full text

Medicine, Immunology, Oncology +15

The activated conformation of integrin β7 is a novel multiple myeloma–specific target for CAR T cell therapy

Naoki Hosen, Yukiko Matsunaga, Kana Hasegawa et al. · Nature Medicine · 2017 · 142 citations

Life Sciences, Cell Biology, Molecular Biology +16

The translation elongation factor eEF2 is a novel tumor-associated antigen overexpressed in various types of cancers

Yusuke Oji, Naoya Tatsumi, Mari Fukuda et al. · International Journal of Oncology · 2014 · 88 citations · Full text

Medicine, Cancer Biology, Oncology +17

CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients

Naoki Hosen, Yoshikazu Matsuoka, Satoshi Kishida et al. · Leukemia · 2012 · 76 citations · Full text

Medicine, Hematology, Oncology +12